ECSP088653A - Formulacion farmacéutica para aerosoles con dos o más principios activos y al menos una sustancia tensoactiva - Google Patents
Formulacion farmacéutica para aerosoles con dos o más principios activos y al menos una sustancia tensoactivaInfo
- Publication number
- ECSP088653A ECSP088653A EC2008008653A ECSP088653A ECSP088653A EC SP088653 A ECSP088653 A EC SP088653A EC 2008008653 A EC2008008653 A EC 2008008653A EC SP088653 A ECSP088653 A EC SP088653A EC SP088653 A ECSP088653 A EC SP088653A
- Authority
- EC
- Ecuador
- Prior art keywords
- aerosols
- substance
- tensoactive
- pharmaceutical formulation
- active principles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a nuevas formulaciones farmacéuticas para aerosoles con al menos dos o más principios activos junto con al menos una sustancia tensioactiva para aplicación inhalativa o nasal. En particular, la invención se refiere a preparaciones farmacéuticas para aerosoles para dosificación operados con propelente con un hidrocarburo fluorado (HFA) como propelente, que contienen una combinación de principios activos de dos o más principios activos, en donde hay al menos un principio activo en forma disuelta además de al menos otro principio activo en forma de partículas suspendidas junto con al menos una sustancia tensioactiva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006006207 | 2006-02-09 | ||
DE102006053374A DE102006053374A1 (de) | 2006-02-09 | 2006-11-10 | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088653A true ECSP088653A (es) | 2008-10-31 |
Family
ID=38266105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008653A ECSP088653A (es) | 2006-02-09 | 2008-07-29 | Formulacion farmacéutica para aerosoles con dos o más principios activos y al menos una sustancia tensoactiva |
Country Status (19)
Country | Link |
---|---|
US (1) | US20070183982A1 (es) |
EP (1) | EP1988874A2 (es) |
JP (1) | JP2009526012A (es) |
KR (1) | KR20080098656A (es) |
CN (1) | CN102861339A (es) |
AR (1) | AR059350A1 (es) |
AU (1) | AU2007213819B2 (es) |
BR (1) | BRPI0707594A2 (es) |
CA (1) | CA2641883A1 (es) |
DE (1) | DE102006053374A1 (es) |
EA (1) | EA014776B1 (es) |
EC (1) | ECSP088653A (es) |
IL (1) | IL193274A0 (es) |
NO (1) | NO20083375L (es) |
NZ (1) | NZ571016A (es) |
PE (2) | PE20120023A1 (es) |
TW (1) | TW200800294A (es) |
UY (1) | UY30139A1 (es) |
WO (1) | WO2007090822A2 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2391563T5 (es) * | 2004-07-02 | 2022-10-26 | Boehringer Ingelheim Int | Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor |
DE102006017320A1 (de) * | 2006-04-11 | 2007-10-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel |
GB0712454D0 (en) | 2007-06-27 | 2007-08-08 | Generics Uk Ltd | Pharmaceutical compositions |
EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
EP2662472B1 (de) | 2009-03-31 | 2019-02-27 | Boehringer Ingelheim International Gmbh | Verfahren zur Beschichtung einer Oberfläche eines Bauteils |
EP3508239B1 (de) | 2009-05-18 | 2020-12-23 | Boehringer Ingelheim International GmbH | Adapter, inhalationseinrichtung und zerstäuber |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
JP5658268B2 (ja) | 2009-11-25 | 2015-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
SG181050A1 (en) | 2009-11-25 | 2012-07-30 | Boehringer Ingelheim Int | Nebulizer |
WO2011160932A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2012087094A1 (es) * | 2010-12-21 | 2012-06-28 | Techsphere S.A. De C.V. | Composición farmacéutica inhalable para el tratamiento del asma por administración vía aérea mediante un succionador de emulación de aerosol |
WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
GB201306984D0 (en) * | 2013-04-17 | 2013-05-29 | Mexichem Amanco Holding Sa | Composition |
WO2015018904A1 (en) | 2013-08-09 | 2015-02-12 | Boehringer Ingelheim International Gmbh | Nebulizer |
PL2835146T3 (pl) | 2013-08-09 | 2021-04-06 | Boehringer Ingelheim International Gmbh | Nebulizator |
RU2536253C1 (ru) * | 2013-10-09 | 2014-12-20 | Шолекс Девелопмент Гмбх | Комбинированный аэрозольный препарат для лечения болезней органов дыхания |
WO2015169759A1 (en) | 2014-05-07 | 2015-11-12 | Boehringer Ingelheim International Gmbh | Nebulizer and container |
BR112016023983B1 (pt) | 2014-05-07 | 2022-10-18 | Boehringer Ingelheim International Gmbh | Contentor para um nebulizador, nebulizador para um fluido e método para conectar um contentor a um dispositivo indicador |
US10722666B2 (en) | 2014-05-07 | 2020-07-28 | Boehringer Ingelheim International Gmbh | Nebulizer with axially movable and lockable container and indicator |
EP2985019B1 (en) | 2014-08-16 | 2021-10-20 | Church & Dwight Co., Inc. | Nasal composition having anti-viral properties |
EP3280393A1 (en) * | 2015-04-10 | 2018-02-14 | 3M Innovative Properties Company | Formulation and aerosol canisters, inhalers, and the like containing the formulation |
GB2573297A (en) * | 2018-04-30 | 2019-11-06 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
CN110876723A (zh) * | 2018-09-06 | 2020-03-13 | 天津金耀集团有限公司 | 一种含有表面活性剂的异丙托溴铵喷雾剂 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1230472A (es) * | 1967-07-10 | 1971-05-05 | ||
DE3767615D1 (de) * | 1986-03-10 | 1991-02-28 | Kurt Burghart | Pharmazeutikum sowie verfahren zu seiner herstellung. |
WO1992022286A1 (en) * | 1991-06-12 | 1992-12-23 | Minnesota Mining And Manufacturing Company | Albuterol sulfate suspension aerosol formulations |
US5503869A (en) * | 1994-10-21 | 1996-04-02 | Glaxo Wellcome Inc. | Process for forming medicament carrier for dry powder inhalator |
EP0806940B1 (en) * | 1994-12-22 | 2003-04-09 | AstraZeneca AB | Aerosol drug formulations |
US6392962B1 (en) * | 1995-05-18 | 2002-05-21 | Rmp, Inc. | Method of sleep time measurement |
GB9626960D0 (en) * | 1996-12-27 | 1997-02-12 | Glaxo Group Ltd | Valve for aerosol container |
GB2332372B (en) * | 1997-12-08 | 2002-08-14 | Minnesota Mining & Mfg | Pharmaceutical aerosol compositions |
RU2218152C2 (ru) * | 1998-06-18 | 2003-12-10 | Берингер Ингельхайм Фармасьютикэлс, Инк. | Фармацевтическая композиция для аэрозолей с двумя или большим количеством действующих веществ |
US6423298B2 (en) * | 1998-06-18 | 2002-07-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
US6352152B1 (en) * | 1998-12-18 | 2002-03-05 | Smithkline Beecham Corporation | Method and package for storing a pressurized container containing a drug |
WO2003045357A1 (en) * | 2001-11-27 | 2003-06-05 | Transform Pharmaceuticals, Inc. | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof |
SE0200312D0 (sv) * | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
GB0207899D0 (en) * | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and cielesonide aerosol formulations |
EP2319584A1 (en) * | 2002-08-29 | 2011-05-11 | Cipla Ltd. | Pharmaceutical products and compositions comprising salmeterol, ciclesonide and tiotropium |
CA2519523C (en) * | 2003-03-20 | 2012-03-13 | Boehringer Ingelheim Pharmaceuticals, Inc. | Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants |
US20050191246A1 (en) * | 2003-12-13 | 2005-09-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powders comprising low molecular dextran and methods of producing those powders |
US20050239778A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim International Gmbh | Novel medicament combinations for the treatment of respiratory diseases |
US7611709B2 (en) * | 2004-05-10 | 2009-11-03 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives |
US7723306B2 (en) * | 2004-05-10 | 2010-05-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation |
US7727962B2 (en) * | 2004-05-10 | 2010-06-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder comprising new compositions of oligosaccharides and methods for their preparation |
ES2391563T5 (es) * | 2004-07-02 | 2022-10-26 | Boehringer Ingelheim Int | Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor |
-
2006
- 2006-11-10 DE DE102006053374A patent/DE102006053374A1/de not_active Withdrawn
-
2007
- 2007-01-29 US US11/668,123 patent/US20070183982A1/en not_active Abandoned
- 2007-02-06 EA EA200801767A patent/EA014776B1/ru not_active IP Right Cessation
- 2007-02-06 KR KR1020087022075A patent/KR20080098656A/ko not_active Application Discontinuation
- 2007-02-06 AU AU2007213819A patent/AU2007213819B2/en not_active Expired - Fee Related
- 2007-02-06 NZ NZ571016A patent/NZ571016A/en not_active IP Right Cessation
- 2007-02-06 CN CN201210380794XA patent/CN102861339A/zh active Pending
- 2007-02-06 WO PCT/EP2007/051095 patent/WO2007090822A2/de active Application Filing
- 2007-02-06 EP EP07704378A patent/EP1988874A2/de not_active Withdrawn
- 2007-02-06 BR BRPI0707594-4A patent/BRPI0707594A2/pt not_active IP Right Cessation
- 2007-02-06 CA CA002641883A patent/CA2641883A1/en not_active Abandoned
- 2007-02-06 JP JP2008553744A patent/JP2009526012A/ja active Pending
- 2007-02-07 PE PE2011001533A patent/PE20120023A1/es not_active Application Discontinuation
- 2007-02-07 AR ARP070100504A patent/AR059350A1/es active Pending
- 2007-02-07 PE PE2007000132A patent/PE20070951A1/es not_active Application Discontinuation
- 2007-02-08 TW TW096104535A patent/TW200800294A/zh unknown
- 2007-02-08 UY UY30139A patent/UY30139A1/es not_active Application Discontinuation
-
2008
- 2008-07-29 EC EC2008008653A patent/ECSP088653A/es unknown
- 2008-08-04 NO NO20083375A patent/NO20083375L/no not_active Application Discontinuation
- 2008-08-06 IL IL193274A patent/IL193274A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007090822A3 (de) | 2007-11-08 |
CA2641883A1 (en) | 2007-08-16 |
DE102006053374A1 (de) | 2007-08-16 |
JP2009526012A (ja) | 2009-07-16 |
BRPI0707594A2 (pt) | 2011-05-10 |
EA014776B1 (ru) | 2011-02-28 |
IL193274A0 (en) | 2009-08-03 |
KR20080098656A (ko) | 2008-11-11 |
NO20083375L (no) | 2008-10-30 |
UY30139A1 (es) | 2007-09-28 |
PE20120023A1 (es) | 2012-02-13 |
WO2007090822A2 (de) | 2007-08-16 |
EP1988874A2 (de) | 2008-11-12 |
CN102861339A (zh) | 2013-01-09 |
TW200800294A (en) | 2008-01-01 |
AR059350A1 (es) | 2008-03-26 |
NZ571016A (en) | 2012-01-12 |
PE20070951A1 (es) | 2007-09-24 |
EA200801767A1 (ru) | 2009-02-27 |
AU2007213819A1 (en) | 2007-08-16 |
AU2007213819B2 (en) | 2012-11-15 |
US20070183982A1 (en) | 2007-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088653A (es) | Formulacion farmacéutica para aerosoles con dos o más principios activos y al menos una sustancia tensoactiva | |
DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
CL2015001959A1 (es) | (divisional solicitud 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos | |
ECSP088403A (es) | Formulacion farmaceutica de absorción oral y su método de administracion | |
PE20160853A1 (es) | Terapia combinada para enfermedad pulmonar obstructiva cronica (epoc) | |
BR112014030820A2 (pt) | formulação de anticorpos | |
BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
CL2007003356A1 (es) | Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades. | |
CL2007003587A1 (es) | Compuestos derivados de pirimidinas sustituidas; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para tratar o prevenir la infeccion de la hepatitis c. | |
BR112015027017A2 (pt) | composições farmacêuticas inaláveis e dispositivos inaladores que contêm as mesmas | |
PE20150773A1 (es) | Composiciones farmaceuticas para la liberacion sostenida de fenilefrina | |
CL2023000998A1 (es) | Formulación farmacéutica para inhalador presurizado de dosis medidas | |
NO20074854L (no) | Farmasoytiske aerosolformuleringer for komprimerte, utmalte doseinhalatorer omfattende et sekvestreringsmiddel | |
UY30241A1 (es) | Aerosoles dosificadores para la administracion de preparaciones farmaceuticas | |
AR052048A1 (es) | Composiciones farmaceuticas para el tratamiento de la celulitis | |
CO6270213A2 (es) | Composiciones farmaceuticas que comprenden acido montelukast y un unhibidor depde-4 o un corticoesteroide inhalado para administracion por inhalacion | |
UY29403A1 (es) | Composiciones farmacéutica sólida que comprende telitromicina. | |
AR086491A1 (es) | Composicion farmaceutica que comprende fexofenadina | |
PE20240808A1 (es) | Composiciones, metodos y sistemas para la administracion de farmacos en aerosol | |
TH97646A (th) | องค์ประกอบทางเภสัชกรรมชนิดเป็นละอองที่มีสองสารแสดงฤทธิ์ หรือมากกว่าและที่อย่างน้อยที่สุดมีหนึ่งสารลดแรงตึงผิว | |
TH97646B (th) | องค์ประกอบทางเภสัชกรรมชนิดเป็นละอองที่มีสองสารแสดงฤทธิ์ หรือมากกว่าและที่อย่างน้อยที่สุดมีนหึ่งสารลดแรงตึงผิว | |
CR9941A (es) | Formacion farmaceutica de absorcion oral y su metodo de administracion |